Balanced news tone
News Sentiment
ADVB sentiment intelligence
Advanced Biomed Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
79/100 classification confidence.
directly relevant articles
high-authority source matches
+3.4% over one week, +14.7% over four weeks, trend inactive, and below fair value.
Qiagen stock holds steady as diagnostics demand shapes long term outlook
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Qiagen stock holds steady as diagnostics demand shapes long term outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 14 Jul 2026 09:00
- Source
- Ad Hoc News
Qiagen stock holds steady as diagnostics demand supports long-term growth
- Tone
- Positive 66/100
- Event
- Macro sensitivity
- Published
- 13 Jul 2026 06:08
- Source
- Ad Hoc News
Number of shareholders of Advanced Biomed Inc. – NASDAQ:ADVB
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 03:31
- Source
- TradingView
Qiagen stock reflects steady diagnostics demand as investors weigh long-term growth drivers
- Tone
- Positive 66/100
- Event
- Macro sensitivity
- Published
- 12 Jul 2026 12:19
- Source
- Ad Hoc News
Roche stock holds steady as pharma giant leans on diagnostics and oncology strength
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jul 2026 08:31
- Source
- Ad Hoc News
Price to book forward of Advanced Biomed Inc. – NASDAQ:ADVB
This article provides the "Price to book forward" for Advanced Biomed Inc. (NASDAQ: ADVB) as listed on TradingView. It indicates that the market was closed at the time of viewing, with no trades having occurred. The content primarily features navigation links and disclaimers rela
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 17:39
- Source
- TradingView
Labcorp stock holds its business focus. Clinical diagnostics remain the core.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 09:51
- Source
- Ad Hoc News
Price to earnings forward of Advanced Biomed Inc. – NASDAQ:ADVB
This article briefly mentions the "Price to earnings forward" metric for Advanced Biomed Inc. (NASDAQ: ADVB). It appears to be a stub or a section from a financial data platform, providing minimal direct information beyond the company name and stock ticker.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jul 2026 04:11
- Source
- TradingView
Price to sales forward of Advanced Biomed Inc. – NASDAQ:ADVB
The article focuses on the "Price to sales forward" metric for Advanced Biomed Inc. (NASDAQ: ADVB). It appears to be a stub or a section of a larger financial analysis tool, likely from TradingView, providing only a heading for this specific financial data point. No actual values
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 23:10
- Source
- TradingView
Enterprise value to EBIT forward of Advanced Biomed Inc. – NASDAQ:ADVB
This article provides financial data for Advanced Biomed Inc. (NASDAQ: ADVB), focusing on its enterprise value to EBIT forward. It indicates that the market was closed at the time of publication with no trades, and the content is primarily a data placeholder from TradingView.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 20:40
- Source
- TradingView
Labcorp stock holds steady as investors watch the next filing cycle
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 08:31
- Source
- Ad Hoc News
Advanced Biomed (NASDAQ: ADVB) investors approve all 2026 meeting proposals
Advanced Biomed Inc. (NASDAQ: ADVB) stockholders approved all five proposals at their annual meeting on June 30, 2026. These approvals included the election of five directors, a non-binding endorsement of executive compensation, annual advisory votes on pay, and the ratification
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 08:41
- Source
- Stock Titan
Advanced Biomed Inc. 8-K Filing: Company Details, Emerging Growth Status, and Nasdaq Listing for 2026
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Jul 2026 00:57
- Source
- Minichart
ADVB - Advanced Biomed Inc Earnings
This article provides a detailed financial overview of Advanced Biomed Inc (ADVB), including its last close price, market capitalization, earnings per share, and other key financial ratios and performance metrics. It lists short interest, insider and institutional ownership, prof
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jul 2026 00:39
- Source
- Finviz
Advanced Biomed (NASDAQ: ADVB) selling Taiwan R&D subsidiary for $490K
Advanced Biomed Inc. (NASDAQ: ADVB) is selling its wholly-owned Taiwan R&D subsidiary, which focuses on biomedical research and development and the A+PerfusC 3D cell culture platform, for $490,000 to an unrelated third party. The transaction, reported in an 8-K filing, is expecte
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 20:38
- Source
- Stock Titan
Advanced Biomed - To Sell Taiwan Subsidiary For $490,000 - SEC Filing
Advanced Biomed (ADVB) has announced its intention to sell its Taiwan subsidiary for $490,000, according to a recent SEC filing. This information was reported by Refinitiv.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 08:39
- Source
- TradingView
Advanced Biomed to Divest Taiwan Subsidiary for $490,000; Closing Expected Within Three Months
Advanced Biomed (ADVB) has entered into a Share Purchase Agreement to sell its Taiwan subsidiary for $490,000 to an unrelated third party. This divestiture includes its biomedical R&D operations and the A+PerfusC 3D cell culture platform. The move is aimed at refocusing the compa
- Tone
- Positive 67/100
- Event
- Market update
- Published
- 01 Jul 2026 08:38
- Source
- TradingView
Advanced Biomed Inc. Sells Taiwan Subsidiary for $490,000 in Share Purchase Agreement – Nasdaq: ADVB 8-K Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 00:37
- Source
- Minichart
Advanced Biomed | 10-Q: Q2 2026 Earnings Report
This document is the 10-Q filing for Advanced Biomed's Q2 2026 earnings report. Further details about the financial performance for the quarter would be contained within the omitted content of this document. It serves as an official report to the SEC regarding the company's finan
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Jun 2026 21:39
- Source
- Moomoo
Miaozhu Zhao entered into a Share Purchase Agreement to acquire Advanced Biomed Inc. from Advanced Biomed Inc. for $0.49 million.
Miaozhu Zhao has entered into a Share Purchase Agreement to acquire Advanced Biomed Inc. for $0.49 million. The transaction is expected to be completed within three months from the agreement date of June 30, 2026. This acquisition involves a cash consideration paid towards the co
- Tone
- Positive 60/100
- Event
- Deals and strategy
- Published
- 28 Jun 2026 00:10
- Source
- marketscreener.com
Agilent (A) Stock Trades Up, Here Is Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- TradingView
Advanced Biomed Inc (ADVB) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Advanced Biomed Inc (ADVB), detailing its support, resistance, and key technical indicators. It presents a summary of various indicators like MACD, RSI, KDJ, and Moving Averages, which collectively suggest a "Sell" signal for the stoc
- Tone
- Negative 35/100
- Event
- Market update
- Published
- 23 Jun 2026 07:10
- Source
- TradingKey
Labcorp Stock - Analyst and consensus view at the start of the week
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 22 Jun 2026 07:00
- Source
- Ad Hoc News
Thermo Fisher Stock - Analyst consensus and Sunday background
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 21 Jun 2026 07:00
- Source
- Ad Hoc News
Danaher Stock - long-term strategy in life sciences
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 07:00
- Source
- Ad Hoc News
Quest Diagnostics Stock - Analyst targets, sector review and weekly recap
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 19 Jun 2026 16:09
- Source
- Ad Hoc News
Qiagen Stock - Friday review and sector comparison
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 07:00
- Source
- Ad Hoc News
Bachem Stock - Analyst consensus and pipeline focus
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 18 Jun 2026 20:19
- Source
- Ad Hoc News
Advanced Biomed Inc (ADVB) Institutional Confidence
This article provides details on the institutional confidence in Advanced Biomed Inc (ADVB), including shareholder activity and the number of shares held by key individuals and firms. It shows that while some individual holders maintain significant positions, institutional holder
- Tone
- Positive 62/100
- Event
- Market update
- Published
- 18 Jun 2026 11:40
- Source
- TradingKey
Advanced Biomed Inc (ADVB) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Advanced Biomed Inc (ADVB), focusing on future EPS and revenue growth estimates. It notes that relevant data for financial forecasting, including EPS, revenue, net profit, and EBIT, has not yet been disclosed by the company. The info
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 11:40
- Source
- TradingKey